Centene Corporation (CNC)

NYSE Health Care Managed Health Care S&P 500
$69.74
-4.43 (-5.97%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$2.92
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 27, 2026Sep/2026$0.07$0.58+728.6%

Our record of CNC's reports since we began tracking; it grows each quarter.

Latest results, in brief

All CNC 8-K briefs →
Oct 26, 7:05 PM ET

Centene raises 2026 adjusted EPS guidance to greater than $5.20 after Q3 results

Positive guidance 2.02

Centene reported third quarter 2026 results on October 27, 2026, with a GAAP diluted loss of $(0.14) per share and adjusted diluted EPS of $0.58, compared with $0.50 a year earlier. The company raised its full-year 2026 adjusted diluted EPS guidance by $0.40 to greater than $5.20 and its GAAP diluted EPS guidance to greater than $3.46. For shareholders, the higher guidance and improved quarterly profit compared with 2025 point to a faster earnings recovery than the company had previously expected.

  • Q3 2026 GAAP diluted loss per share was $(0.14), compared with a $(13.50) loss in Q3 2025, which included a $6.7 billion goodwill impairment.
  • Q3 2026 adjusted diluted EPS was $0.58, up from $0.50 in Q3 2025.
  • Full-year 2026 adjusted diluted EPS guidance rose to greater than $5.20; GAAP diluted EPS guidance is greater than $3.46.
  • Total debt was reduced by $1.1 billion since June 30, 2026, including full redemption of the 2027 Senior Notes in October 2026.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$45.10B+0.5% $-0.14— -$71.00M-0.2%
Jun 2026$44.38B+4.5% $2.19— $1.09B2.5%
Mar 2026$44.66B+5.1% $3.11+18.3% $1.54B3.5%
Dec 2025$44.73B+23.2% $-2.24-461.3% -$1.10B-2.5%
Sep 2025$44.90B+21.7% $-13.50-1092.6% -$6.63B-14.8%
Jun 2025$42.47B+18.1% $-0.51-123.6% -$253.00M-0.6%
Mar 2025$42.49B+16.9% $2.63+21.8% $1.31B3.1%
Dec 2024$36.30B+2.7% $0.62+520.0% $283.00M0.8%

From Centene Corporation's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$174.58B+20.0% $-13.53-314.4%-3.8%
FY2024$145.50B+3.9% $6.31+27.5%2.3%
FY2023$140.09B+3.4% $4.95+139.1%1.9%
FY2022$135.48B+14.8% $2.07-9.2%0.9%
FY2021$117.98B+13.7% $2.28-26.9%1.1%

Frequently asked questions

When is Centene's next earnings date?

Centene has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Centene earn last quarter?

For the quarter ended Sep 2026, Centene reported diluted EPS of $-0.14 on revenue of $45.10B (+0.5%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.